Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00739115 · ClinicalTrials.gov registry record · NA

The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study

A NA study, sponsored by Hawaii Pacific Health.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT00739115: Completed NA study, sponsored by Hawaii Pacific Health.

NCT00739115 is a NA study that has completed, run by Hawaii Pacific Health. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00739115, a NA study, has completed, sponsored by Hawaii Pacific Health.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and utility of using heliox gas in combination with nasal CPAP in premature infants. The investigators hypothesize that using heliox gas in combination with nasal CPAP will results in decreased early nasal CPAP failure requiring intubation and mechanical ventilation.

Interventions

  • OTHER Heliox gas

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2008-09
Est. Completion 2011-08
Phase NA
Hawaii Pacific Health

7 total trials

What the finished NCT00739115 record still lists

NCT00739115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Heliox gas is the first listed.

NCT00739115 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00739115 about?

NCT00739115 is a clinical study titled "The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study". The purpose of this study is to evaluate the safety and utility of using heliox gas in combination with nasal CPAP in premature infants. The investigators hypothesize that using heliox gas in combination with nasal CPAP will results in decreased early nasal CPAP failure requiring intubation and mech...

What is the current status of trial NCT00739115?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-09. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00739115?

The interventions under investigation include: Heliox gas (OTHER).

Who is sponsoring clinical trial NCT00739115?

This trial is sponsored by Hawaii Pacific Health, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00739115's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00739115, the US trial registry maintained by the National Library of Medicine. NCT00739115 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.